
J&J eyes up to $5.5B to settle talcum-powder cancer lawsuits
Johnson & Johnson has set aside up to $5.5 billion to resolve about 76,000 US lawsuits alleging its talcum powder products caused ovarian cancer, offering plaintiffs up to $3 billion in 2027 with any remaining payouts after 2028; the deal would require acceptance by at least 95% of the claimants’ law firms to proceed. The company has faced decades of talc litigation, has defended the safety of its products, and has already shifted away from talc-based powder in North America (2020) and worldwide (2023).












